media – Page 516 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

New MDSAP rules from Health Canada will raise cost for audit and force some companies out of Canada.

Health Canada’s new safety audit rules are going to increase costs and expected to expel some medical devices players out of the country, the new rules are expected to bring a huge shortage of products for the patients in Canada.
- Source: Ddu -Jophy Joseph
- 593
- May 7, 2018
Canada medical device Policies
Moderna and Merck Expand mRNA Cancer Vaccines Collaboration

Expansion Includes the Joint Development of Moderna’s KRAS Oncogene Program and Other Potential mRNA Cancer Vaccines; Merck to Make Equity Investment in Moderna
- Source: investors.merck
- 525
- May 7, 2018
Merck mRNA cancer vaccines
Shingrix approved in Europe and Japan for the prevention of shingles in adults aged 50 and over

The only shingles vaccine to achieve ≥90% efficacy across all age groups studied
- Source: gsk
- 613
- May 7, 2018
EC GSK post-herpetic neuralgia Shingrix
Healthcare sector startups to watch in 2018

Lately, Biotech and immunotherapy have been widely covered by media, but there’s more to healthcare than taking leaps of faith on new tech. New companies are addressing administrative functions, personalized medicine, and proactive wellness in their approach to the health industry.
- Source: Crunchbase
- 807
- May 7, 2018
healthcare Market Views
OpenMedReady to validate Patient identity & data Integrity for RPM

Several Mobile-Health companies are joining hands to create a clinician-facing platform for assuring data quality and patient identification in remote patient monitoring programs.
- Source: mHealth Intelligence
- 743
- May 7, 2018
digital health mHealth Researches
FDA approve iSchemaView’s 3D CTA

iSchemaView has received FDA approval for its latest product, RAPID CTA, a 3D imaging platform for computed tomography angiography (CTA).
- Source: drugdu
- 3,548
- May 4, 2018
digital health FDA imaging New Approvals
Flatiron Health, acquired By Roche, Signs Three-Year Deal with Bristol-Myers

Flatiron announced a three-year agreement with Bristol-Myers Squibb (BMS) a leading pharma company from the US. BMS is planning to use Flatiron’s expertise to expand real-world evidence to develop Bristol’s experimental cancer drugs.
- Source: drugdu
- 665
- May 4, 2018
BMS Company Insights Roche
Three Tactics for Client Management

As a matter of fact, we all can better “manage” our clients.
- Source: drugdu
- 6,771
- May 4, 2018
Client Management Ddu College Tactics
Three Misconceptions and Four Suggestions to Pay Attention to in Foreign Trade

Foreign trade is a highly competitive field with numerous potholes and hidden issues. As a leader in the online pharmaceutical and medical device B2B industry, Ddu staff have in-depth knowledge of these matters. Today we’ll share our take on three misconceptions that are often overlooked and four important suggestions on how to approach your clients.
- Source: Ddu
- 6,731
- May 4, 2018
Ddu College misconceptions suggestions
Harvard’s Wyss Institute partners with Cellectis to recode the human genome

Recode project will use Cellectis’ TALEN gene editing technology to create first virus-resistant human cells for manufacturing therapeutics and developing new cell-based therapies
- Source: immunotherapies
- 647
- May 4, 2018
CAR T-cells Cellectis immunotherapies Market Views

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.